CIVILICA We Respect the Science
(ناشر تخصصی کنفرانسهای کشور / شماره مجوز انتشارات از وزارت فرهنگ و ارشاد اسلامی: ۸۹۷۱)

REDUCING EFFECT OF CARNOSINE ON ADVANCED GLYCATION END PRODUCTS: A SYSTEMATIC REVIEW

عنوان مقاله: REDUCING EFFECT OF CARNOSINE ON ADVANCED GLYCATION END PRODUCTS: A SYSTEMATIC REVIEW
شناسه ملی مقاله: INC15_209
منتشر شده در سومین کنگره بین المللی و پانزدهمین کنگره تغذیه ایران در سال 1397
مشخصات نویسندگان مقاله:

Ramin Ghodsi - Student research committee of Tabriz University of Medical Sciences, Tabriz, Iran
Sorayya Kheirouri - Department of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran

خلاصه مقاله:
Background and Aim: Advanced glycation end products (AGEs) are a group compounds that generate by the binding of amino groups of DNAs, lipids and proteins with sugars in a non-enzymatic reaction. Carnosine is a dipeptide composed of β-alanine and L-histidine with antioxidant properties, which has the ability to inhibit protein carbonylation and glycoxidation. Methods: This systematic review searched all the original articles (in vitro, in vivo and human studies) in English which had examined the effect of carnosine on AGEs formation up to the end of April 2018. An electronic search of Scopus, PubMed, and Google Scholar was conducted. Keywords were searched in all parts of articles. Results: After excluding duplicated data, 133 articles were selected. Studies in about components of carnosine, Review articles and studies based on the protective effects of carnosine on AGEs-induced changes were excluded. 36 articles were chosen for the study which included two human studies, 15 animal studies and 19 in vitro studies. Conclusion: The findings of this systematic review demonstrated that carnosine is an anti-glycating dipeptide, and has the ability to overcome the cross-links induced by reduced sugars; however, there were few human studies.

کلمات کلیدی:
Carnosine ; antioxidant ; Advanced glycation end products ; carbonylation ;

صفحه اختصاصی مقاله و دریافت فایل کامل: https://civilica.com/doc/816243/